Últimas subidas - Macular Diseases - Acquired
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 174 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 149 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 170 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 94 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 95 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 110 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 111 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 119 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 78 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 112 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 110 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 132 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 126 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 128 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
MacTel with foveal atrophy in both eyesvista 114 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 86 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 113 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 120 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 108 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 116 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 136 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 98 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 105 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 105 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 107 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 105 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 119 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 100 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 129 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
Latanoprost induced CMEvista 149 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 147 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 141 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 153 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 165 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 160 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 142 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 162 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 140 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 137 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 147 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 149 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 162 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 145 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 131 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 137 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 135 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 134 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 133 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 137 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 134 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 147 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 140 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 143 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 153 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 169 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 129 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 137 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 121 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 150 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Hydroxychloroquine Toxicityvista 172 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 201 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 208 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 190 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 172 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 172 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 176 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 226 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 228 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 186 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Pseudophakic CME chronicvista 145 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 176 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 170 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 187 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 185 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 193 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 188 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 204 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 192 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 174 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 176 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 207 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 172 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 207 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 184 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 180 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 152 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 169 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 207 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 205 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 148 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 178 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 189 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 190 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 205 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 199 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 148 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 176 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 180 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 191 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 156 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
| 2321 archivos en 24 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
